Periodontal disease severity is related to high levels of C-reactive protein in pre-eclampsia

Journal of Hypertension

Volumn 25, Issue 7, 2007, Pages 1459-1464

  Herrera, Julián A ^a   Parra, Beatriz ^a   Herrera, Enrique ^a   Botero, Javier E ^a   Arce, Roger M ^a   Contreras, Adolfo ^a   López Jaramillo, Patricio ^b  

^a UNIVERSIDAD DEL VALLE   (Colombia)

^b FUNDACIÓN CARDIOVASCULAR DE COLOMBIA   (Colombia)

Author keywords

Bacterial infection; C reactive protein; Chronic periodontitis; Preeclampsia

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MOUTH FLORA; PERIODONTAL DISEASE; PERIODONTITIS; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; RISK FACTOR;

EID: 34250356330     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3281139ea9     Document Type: Article

References (39)

1. Herrera JA, Chaudhuri G, Lopez-Jaramillo P. Is infection a major risk factor for preeclampsia? Med Hypotheses 2001; 57:393-397.
2. Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev 2000; 13:547-558.
3. Offenbacher S, Katz V, Fertik G, Collins J, Boyd D, Maynor G, et al. Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol 1996; 67 (Suppl):1103-1113.
4. Lopez NJ, Smith PC, Gutierrez J. Higher risk of preterm birth and low birth weight in women with periodontal disease. J Dent Res 2002; 81:58-63.
5. Boggess KA, Lieff S, Murtha AP, Moss K, Beck J, Offenbacher S. Maternal periodontal disease is associated with an increased risk for preeclampsia. Obstet Gynecol 2003; 101:227-231.
6. Canakci V, Canakci CF, Canakci H, Canakci E, Cicek Y, Ingec M, et al. Periodontal disease as a risk factor for pre-eclampsia: a case control study. Aust NZ J Obstet Gynaecol 2004; 44:568-573.
7. Oettinger-Barak O, Barak S, Ohel G, Oettinger M, Kreutzer H, Peled M, et al. Severe pregnancy complication (preeclampsia) is associated with greater periodontal destruction. J Periodontol 2005; 76:134-137.
8. Contreras A, Herrera JA, Soto JE, Arce RM, Jaramillo A, Botero JE. Periodontitis is associated with preeclampsia in pregnant women. J Periodontol 2006; 77:182-188.
9. Ridker P, Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores. Circulation 2004; 109:1955-1959.
10. Schwedler SB, Filep JG, Galle J, Wanner C, Potempa LA. C-reactive protein: a family of proteins to regulate cardiovascular function. Am J Kidney Dis 2006; 47:212-222.
11. Ustun Y, Engin-Ustun Y, Kamaci M. Association of fibrinogen and C-reactive protein with severity of preeclampsia. Eur J Obstet Gynecol Reprod Biol 2005; 121:154-158.
12. Azizia MM, Irvine LM, Coker M, Sanusi FA. The role of C-reactive protein in modern obstetric and gynecological practice. Acta Obstet Gynecol Scand 2006; 85:394-401.
13. Rebelo I, Caravalho-Guerra, Pereira-Leite L, Quintnhila A. Comparative study of lactoferrin and other blood markers of inflammatory stress between preeclamptic and normal pregnancies. Eur J Obstet Gynecol Reprod Biol 1996; 64:167-173.
14. Teran E, Escudero C, Moya W, Flores M, Vallance P, Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia. Int J Gynaecol Obstet 2001; 75:243-249.
15. Bodnar LM, Ness RB, Harger GF, Roberts JM. Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol 2005; 162:1198-1206.
16. Qiu C, Luthy DA, Zhang C, Walsh SW, Leisenring WM, Williams MA. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am J Hypertens 2004; 17:154-160.
17. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999; 4:1-6.
18. Moller AJ. Microbiological examination of root canals and periapical tissues of human teeth. Methodological studies. Odontol Tidskr 1966; 74 (Suppl):380.
19. Doan N, Contreras A, Flynn J, Morrison J, Slots J. Proficiencies of three anaerobic culture systems for recovering periodontal pathogenic bacteria. J Clin Microbiol 1999; 37:171-174.
20. Slots J. Rapid identification of important periodontal microorganisms by cultivation. Oral Microbiol Immunol 1986; 1:48-57.
21. Slots J, Reynolds HS. Long-wave UV light fluorescence for identification of black-pigmented Bacteroides spp. J Clin Microbiol 1982; 16:1148-1151.
22. Rams TE, Feik D, Young V, Hammond BF, Slots J. Enterococci in human periodontitis. Oral Microbiol Immunol 1992; 7:249-252.
23. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol 1998; 25:134-144.
24. Beck JD, Pankow J, Tyroler HA, Offenbacher S. Dental infections and atherosclerosis. Am Heart J 1999; 138:S528-S533.
25. Beck JD, Offenbacher S, Williams R, Gibbs P, Garcia R. Periodontitis: a risk factor for coronary heart disease? Ann Periodontol 1998; 3:127-141.
26. Katz J, Chaushu G, Sharabi Y. On the association between hypercholesterolemia, cardiovascular disease and severe periodontal disease. J Clin Periodontol 2001; 28:865-868.
27. Dorn BR, Dunn WA Jr, Progulske-Fox A. Invasion of human coronary artery cells by periodontal pathogens. Infect Immun 1999; 67:5792-5798.
28. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000; 71:1554-1560.
29. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998; 179:1359-1375.
30. Goodson JM, Tanner AC, Haffajee AD, Sornberger GC, Socransky SS. Patterns of progression and regression of advanced destructive periodontal disease. J Clin Periodontol 1982; 9:472-481.
31. Madianos PN, Lieff S, Murtha AP, Boggess KA, Auten RL Jr, Beck JD, et al. Maternal periodontitis and prematurity. Part II: maternal infection and fetal exposure. Ann Periodontol 2001; 6:175-182.
32. Offenbacher S, Lieff S, Boggess KA, Murtha AP, Madianos PN, Champagne CM, et al. Maternal periodontitis and prematurity. Part I: obstetric outcome of prematurity and growth restriction. Ann Periodontol 2001; 6:164-174.
33. Roberts JM. Preeclampsia: what we know and what we do not know. Semin Perinatol 2000; 24:24-28.
34. Lopez-Jaramillo P, Garcia RG, Lopez M. Preventing pregnancy-induced hypertension: are there regional differences for this global problem? J Hypertens 2005; 23:1121-1129.
35. Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 1997; 37:240-249.
36. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180:499-506.
37. Faas MM, Schuiling GA. Pre-eclampsia and the inflammatory response. Eur J Obstet Gynecol Reprod Biol 2001; 95:213-217.
38. von DP, Magee LA. Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction? Acta Obstet Gynecol Scand 2002; 81:642-648.
39. García RG, Celedón J, Sierra-Laguado J, Alarcón MA, Luengas C, Silva F, et al. Raised C-reactive protein and impaired flow mediated vasodilation precede the development of preeclampsia. Am J Hypertens 2007; 20:98-103.